ACHV
Achieve Life Sciences Inc.
$4.70
+$0.01(+0.20%)
43
Overall
40
Value
63
Tech
28
Quality
Market Cap
$256.06M
Volume
421.55K
52W Range
$1.84 - $5.78
Target Price
$16.71
Company Overview
| Mkt Cap | $256.06M | Price | $4.70 |
| Volume | 421.55K | Change | +0.20% |
| P/E Ratio | -6.4 | Open | $4.69 |
| Revenue | -- | Prev Close | $4.69 |
| Net Income | $-39.8M | 52W Range | $1.84 - $5.78 |
| Div Yield | N/A | Target | $16.71 |
| Overall | 43 | Value | 40 |
| Quality | 28 | Technical | 63 |
No chart data available
About Achieve Life Sciences Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc., which is headquartered in Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACHV | $4.70 | +0.2% | 421.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Achieve Life Sciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW